Neil Harris Cohen - Net Worth and Insider Trading
Neil Harris Cohen Net Worth
The estimated net worth of Neil Harris Cohen is at least $8,939 dollars as of 2024-05-05. Neil Harris Cohen is the Director of Chemomab Therapeutics Ltd and owns about 10,000 shares of Chemomab Therapeutics Ltd (CMMB) stock worth over $7,400. Neil Harris Cohen is also the Director of Anchiano Therapeutics Ltd and owns about 151 shares of Anchiano Therapeutics Ltd (CMMB) stock worth over $1,539. Details can be seen in Neil Harris Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Neil Harris Cohen has not made any transactions after 2022-11-16 and currently still holds the listed stock(s).
Transaction Summary of Neil Harris Cohen
Neil Harris Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil Harris Cohen owns 1 companies in total, including Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Neil Harris Cohen’s form 4 insider trades.
Insider Ownership Summary of Neil Harris Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd | 2022-11-16 | director |
Neil Harris Cohen Latest Holdings Summary
Neil Harris Cohen currently owns a total of 2 stocks. Among these stocks, Neil Harris Cohen owns 10,000 shares of Chemomab Therapeutics Ltd (CMMB) as of November 16, 2022, with a value of $7,400 and a weighting of 82.79%. Neil Harris Cohen also owns 151 shares of Anchiano Therapeutics Ltd (CMMB) as of March 16, 2021, with a value of $1,539 and a weighting of 17.21%.
Latest Holdings of Neil Harris Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd | 2022-11-16 | 10,000 | 0.74 | 7,400 |
| CMMB | Anchiano Therapeutics Ltd | 2021-03-16 | 151 | 10.19 | 1,539 |
Holding Weightings of Neil Harris Cohen
Neil Harris Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil Harris Cohen has made a total of 4 transactions in Chemomab Therapeutics Ltd (CMMB) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Chemomab Therapeutics Ltd is the sale of 2,409 shares on November 16, 2022, which brought Neil Harris Cohen around $4,818.
According to the SEC Form 4 filings, Neil Harris Cohen has made a total of 1 transactions in Anchiano Therapeutics Ltd (CMMB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Anchiano Therapeutics Ltd is the acquisition of 151 shares on March 16, 2021, which cost Neil Harris Cohen around $99,998.
Insider Trading History of Neil Harris Cohen
- 1
Neil Harris Cohen Trading Performance
GuruFocus tracks the stock performance after each of Neil Harris Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neil Harris Cohen is -15.46%. GuruFocus also compares Neil Harris Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neil Harris Cohen within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neil Harris Cohen's insider trading performs compared to the benchmark.
Performance of Neil Harris Cohen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.89 | | | | | |
| Relative Return to S&P 500(%) | -1.28 | | | | | |
Neil Harris Cohen Ownership Network
Neil Harris Cohen Owned Company Details
What does Chemomab Therapeutics Ltd do?
Who are the key executives at Chemomab Therapeutics Ltd?
Neil Harris Cohen is the director of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Chief Medical Officer Matthew Bejosa Frankel .
Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary
Over the past 18 months, Neil Harris Cohen made 1 insider transaction in Chemomab Therapeutics Ltd (CMMB) with a net sale of 2,409. Other recent insider transactions involving Chemomab Therapeutics Ltd (CMMB) include a net sale of 582,023 shares made by George Adi Mor , a net sale of 336,900 shares made by Orbimed Israel Biofund Gp Limited Partnership ,
In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 921,332 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 921,332 shares.
Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chemomab Therapeutics Ltd Insider Transactions
Neil Harris Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Neil Harris Cohen. You might contact Neil Harris Cohen via mailing address: C/o Anchiano Therapeutics Ltd., One Kendall Sq., Bldg 1400e, Ste 14-105, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
